Marker Therapeutics
Earnings Surprise
Analysts estimated MRKR earnings of $-0.20 per share this quarter (Q4). MRKR's actual earnings were $-0.09 per share.
MRKR EPS surprise of 55.13%Analysts estimated MRKR earnings of $-0.46 per share this quarter (Q3). MRKR's actual earnings were $-0.12 per share.
MRKR EPS surprise of 73.86%Analysts estimated MRKR earnings of $-0.42 per share this quarter (Q2). MRKR's actual earnings were $-0.29 per share.
MRKR EPS surprise of 30.66%Analysts estimated MRKR earnings of $-0.50 per share this quarter (Q1). MRKR's actual earnings were $-0.36 per share.
MRKR EPS surprise of 28.04%Analysts estimated MRKR earnings of $-0.22 per share this quarter (Q4). MRKR's actual earnings were $-0.42 per share.
MRKR EPS surprise of -87.58%Analysts estimated MRKR earnings of $-0.40 per share this quarter (Q3). MRKR's actual earnings were $-0.26 per share.
MRKR EPS surprise of 34.64%Analysts estimated MRKR earnings of $-0.44 per share this quarter (Q2). MRKR's actual earnings were $-0.25 per share.
MRKR EPS surprise of 43.00%Analysts estimated MRKR earnings of $-0.26 per share this quarter (Q1). MRKR's actual earnings were $-0.27 per share.
MRKR EPS surprise of -5.06%Analysts estimated MRKR earnings of $-1.02 per share this quarter (Q4). MRKR's actual earnings were $-0.48 per share.
MRKR EPS surprise of 112.50%